Dreyer Scott 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Aug 15, 2025
Insider Transaction Report
Form 4
Dreyer Scott
EVP & Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-08-13$38.03/sh−4,861$184,881→ 103,613 total - Exercise/Conversion
Common Stock
2025-08-13$21.34/sh+4,861$103,734→ 108,474 total - Exercise/Conversion
Stock Option (Right to Purchase)
2025-08-13−4,861→ 16,389 totalExercise: $21.34Exp: 2030-02-05→ Common Stock (4,861 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.
- [F2]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The option is fully vested and exercisable.